Rivastigmine in the Management of Delirium

NCT01487317 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Delirium

Interventions

DRUG: Rivastigmine transdermal patch
DRUG: placebo patch

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]